Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-048603
Filing Date
2025-04-01
Accepted
2025-04-01 16:35:05
Documents
17
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A crbp-20250401.htm   iXBRL DEF 14A 1101976
2 GRAPHIC img116801110_0.jpg GRAPHIC 712349
3 GRAPHIC img116801110_1.jpg GRAPHIC 712561
4 GRAPHIC img116801110_2.jpg GRAPHIC 582905
5 GRAPHIC img116801110_3.jpg GRAPHIC 607466
  Complete submission text file 0000950170-25-048603.txt   8416483

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20250401.xsd EX-101.SCH 26785
19 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20250401_htm.xml XML 356507
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 25800306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)